CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![predictive medical analytics, digital AI interface, patient data, DNA insights-GettyImages-2262212753]( "Interpreting Early Inflammation Signals: What Early Human Data Tells Us")
Interpreting Early Inflammation Signals: What Early Human Data Tells UsEarly inflammatory signals can mislead without context. Benchmarked human challenge models reveal true biological activity, guiding decisions on mechanism, dosing, and clinical development.
-
![GettyImages-2234439798-AI-Medicine-Trials-Drug-Development]( "Responsible AI In Clinical Trials Starts With How It Is Designed")
Responsible AI In Clinical Trials Starts With How It Is DesignedExplore how trials can responsibly use AI to move faster while keeping human judgment, data protections, and auditability intact.
-
![peptides-preclinical-develop-GettyImages-2264393871]( "Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us")
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells UsBenchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
-
![assay plate, immunology, serology-GettyImages-1425761734]( "Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models")
Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge ModelsHuman challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.
-
![predictive medical analytics, digital AI interface, patient data, DNA insights-GettyImages-2262212753]( "Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance")
Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring ComplianceClear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
Study Experience: Pancreatic Cancer6/17/2026
Discover how access to robust historical datasets is helping sponsors make smarter decisions earlier and increase the likelihood of clinical and regulatory success
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
CENTRAL LABORATORIES PRODUCTS & SERVICES
TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.
Gain confidence in your clinical research data with direct data capture (DDC).
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
Ergomed’s Meticulous Risk-Based Quality Management Approach
As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.
Identify & engage healthcare professionals (HCP) treating eligible patients—in near real-time
Timely physician engagement is critical to therapy adoption. Quest Diagnostics combines near real-time lab data with other data sources including EHR, claims and prescription data to help pharmaceutical teams identify and connect with physicians managing eligible patients at key decision time point in the patient journey.
In today’s competitive pharmaceutical landscape, ensuring that physicians receive timely, relevant information about new therapies is essential. Quest’s unique combination of industry-leading deidentified lab data, enhanced with claims, prescription (Rx), and EHR insights, allows pharma teams to refine targeting, optimize engagement, and drive better patient outcomes.
CENTRAL LABORATORIES SOLUTIONS
- Clinical Data Studio: Unlock The True Power Of Clinical Trial Data
- The Next-Generation Of Clinical Trial Data Management And Operations
- Medidata Research Alliance: Partnerships For Medical Progress
- Leverage AI To Optimize Protocol Design & Study Start-Up
- Site Cloud: End Of Study (EOS)
- A New Blueprint For Transforming Feasibility And Recruitment
- Simplify The Complexities Of RWE Generation
- Advarra Cloud
- Feasibility As A Service From Consulting & Analytics
- Trial Results Summaries
VIDEOS
NEWS
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience